CRISPR

Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’

by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE
Mammoth Project: Dallas’ Colossal Raises $60M to Advance Genetic Engineering and ‘De-Extinction’ Technologies
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid. With a total raise of $75 million to date, the startup aims to have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE
UT Southwestern Team Awarded $8.8M to Participate in Genomic Variation Consortium
by | Oct 25, 2021
The team is led by UTSW assistant professor Gary Hon, Ph.D., who developed Mosaic-seq, a gene engineering technique that helped lead to the grant award. UTSW will now become a research partner in a new $185M National Institutes of Health (NIH) initiative to build on findings of the Human Genome Project.
MORE

Discovery: UNTHSC Works on More Precise CRISPR, UTSW Uses AI in Depression Research

by | Oct 4, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also find out about how a $427,000 NIH grant is helping a UTA team study the healing of cranial injuries, and how Lexus researchers are creating a high-end audio system.
MORE
CRISPR CAS9 gene editing background
UT Southwestern-Linked Startup Exonics Therapeutics Exits in Deal Valued at $1B
by | Jun 17, 2019
The biotech company uses CRISPR technology licensed from UT Southwestern Medical Center in Dallas, and was co-founded by UTSW researcher and faculty member Eric Olson.
MORE
research
R&D: UTA Scientist Seeks Best Rock to Block Nuclear Waste; Grant Enables PTSD Research
by | Sep 7, 2018
Also, you'll learn about advances to treat Duchenne muscular dystrophy and migraines. Here are some of the research projects underway in North Texas that could make lives better.
MORE